Calculation of the combined significance for both the discovery and validation set taken together revealed highly significant P -values of 0.013 and 0.005, respectively.
← all excerpts
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.
2
—
—
The sentences
The initial dose-induced plasma level changes of the above spots 195 and 529 showed again an association with the final response to therapy with a P -value of 0.047 for spot 195 and a borderline significant P -value of 0.054 for spot 529.